Watson Pharma Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. A3-A-6, Phase 1A Verna Industrial Estate, Verna, Salcette, Goa 403722, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3005719315 · DUNS 677605709
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2020-01-23
- NAIDrug Quality Assurance2018-04-26
- VAIDrug Quality Assurance2015-07-21
- VAIDrug Quality Assurance2014-03-14
- VAIDrug Quality Assurance2012-02-08
- NAIDrug Quality Assurance2011-02-02
Drugs this plant is listed as making
4 distinct drugs across 5 products name this site in their FDA label.
- HydrochlorothiazideActavis Pharma, Inc.
- Nortriptyline HydrochlorideMayne Pharma Inc.
- Triamterene and HydrochlorothiazideBluePoint Laboratories
- UrsodiolActavis Pharma, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.